CTLA4 and neoplasm: The reduced size of EBV-induced lymphomas in PD-1/CTLA-4 antibody treated cord-blood humanized mice suggests that cord blood-derived human T cells may be better able to infiltrate lymphomas and kill tumor cells following PD-1/CTLA-4 blockade.